ALEXANDRA MARQUES: Open Payments
NPI 1407585060 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,212 in 210 payments from 27 companies in 2025. Trend: 2023 $3,779 · 2024 $5,003 · 2025 $4,212
Food & beverage: $4,117Education: $95
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 29 | $427 |
| ARGENX US, INC. | 13 | $391 |
| UCB, Inc. | 15 | $361 |
| ABBVIE INC. | 21 | $345 |
| SK Life Science, Inc. | 12 | $264 |
| ACADIA Pharmaceuticals Inc | 10 | $231 |
| Eisai Inc. | 7 | $219 |
| Amgen Inc. | 9 | $210 |
| Genentech USA, Inc. | 10 | $210 |
| Lilly USA, LLC | 11 | $198 |
Products named: VYEPTI, VYVGART HYTRULO, NUPLAZID, Leqembi, KISUNLA, Ocrevus Zunovo, UPLIZNA, NURTEC ODT.
Industry payments across CT — which companies pay providers there.
